We are live on ! Find out more
AMBI

Ambit Biosciences Corp
AMBI

Delisted

AMBI was delisted on the 10th of November, 2014.

Back to rankings

15 hedge funds and large institutions have $36.9M invested in Ambit Biosciences Corp in 2013 Q2 according to their latest regulatory filings, with 15 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
15
Holders Change
+15
Holders Change %
–
% of All Funds
0.49%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
15
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
$10.4M +$10.7M +1,490,769 New
JRJ
2
Jeffrey R. Jay
$7M +$7.15M +1,000,000 New
Fidelity Investments
3
Fidelity Investments
Massachusetts
$5.62M +$5.74M +802,250 New
BBA
4
Baker Bros. Advisors
New York
$5.24M +$5.35M +747,962 New
WC
5
Wexford Capital
Florida
$4.36M +$4.45M +622,500 New
JP Morgan Chase
6
JP Morgan Chase
New York
$1.53M +$1.56M +218,300 New
PRCM
7
Pine River Capital Management
Minnesota
$1.22M +$1.24M +174,100 New
Alyeska Investment Group
8
Alyeska Investment Group
Illinois
$525K +$536K +74,989 New
FM
9
Forward Management
California
$408K +$408K +57,000 New
Goldman Sachs
10
Goldman Sachs
New York
$184K +$188K +26,297 New
Morgan Stanley
11
Morgan Stanley
New York
$174K +$178K +24,834 New
SIP
12
Stoneridge Investment Partners
Pennsylvania
$153K +$157K +21,906 New
TRCT
13
Tower Research Capital (TRC)
New York
$29K +$29.6K +4,144 New
Citigroup
14
Citigroup
New York
$1K +$1.07K +150 New
TCM
15
Tang Capital Management
California
– +$329 +46 New

AMBI Hedge Fund Activity: Q2 2013 in Review

15 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in Ambit Biosciences Corp (AMBI) for Q2 2013, worth a combined $36.9M.

Buyers outnumbered sellers: 15 funds opened new AMBI positions and 0 closed out — a net gain of 15 holders — while 0 added to existing stakes and 0 trimmed.

  • 15 institutional investors held Ambit Biosciences Corp (AMBI) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $36.9M of Ambit Biosciences Corp stock for Q2 2013.
  • 15 funds opened new Ambit Biosciences Corp positions in Q2 2013 and 0 closed out, a net change of +15 holders.

Based on aggregated 13F filings for Q2 2013.